emcure nz limited is a pharmaceutical company that offers a wide range of products and services, including orals, injectables, and biotherapeutics, with a presence in over 70 countries. Emcure is engaged in developing, manufacturing, and marketing pharmaceutical products across major therapeutic areas, with a focus on research and development. The company has expertise in manufacturing ARV APIs and a facility for the production of Immunosuppressant API. Emcure is recognized for its work in chiral chemistry and has commercialized products such as Atazanavir, Ritonavir, Dolutegravir, and Tenofovir. Additionally, the company is focused on research in complex APIs, multiple dosage form development, bio-therapeutics, and mRNA development, with plans to develop a growing vaccine pipeline based on the in-house developed mRNA platform.
Legal Address
Plot No. P-1 & P-2, It-Bt Park, Phase-Ii, M.I.D.C.
Pune; Maharashtra;
Postal Code: 411057
Contact Details: Purchase the Emcure Pharmaceuticals Ltd. report to view the information.
Website: http://www.emcure.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service